Manufacturing and Production

Showing 15 posts of 5860 posts found.

celgene_hugin

Big pharma appointments to PhRMA Board

April 15, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, Celgene, Merck, Pfizer, PhRMA

Chairman and chief executive of Celgene Robert Hugin has been elected chairman of the Pharmaceutical Research and Manufacturers of America …

Eisai appoints chief clinical officer

April 12, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Eisai

Eisai has announced the immediate appointment of Lynn Kramer to the newly created position of chief clinical officer of Eisai …

Bristol-Myers Squibb appoints executive as another retires

April 10, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS

Bristol-Myers Squibb has announced the appointment of Francis Cuss as executive VP and chief scientific officer following Elliott Sigal’s intentions …

New head at European Medicines Agency

April 8, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA

The European Medicines Agency has appointed Agneta Brandt as the new head of Infrastructure Services. Brandt joins the Agency from …

Star commercial academy appoints director

March 28, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Star

Gary Lunt has been appointed to the newly created role of Business Development director with training agency STAR Commercial Academy. …
stuart_mcguire_12a

Chiltern announces two promotions

March 26, 2013 Manufacturing and Production, Research and Development, Sales and Marketing chiltern

Global clinical contract research organisation Chiltern International has announced the promotions of Stuart McGuire and Jim Szymeczek.“I am pleased to …

Africa rising

March 26, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Africa, Lunt

Africa has been a byword for poverty, disease and political turmoil for generations, and many people in the most developed …

New chief executive for Eyevensys

March 26, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Eyevensys

Gene therapy development firm Eyevensys has announced the appointment of Dr Ivan Cohen-Tanugi as chief executive.Cohen-Tanugi has over 20 years’ …
mike_williams_leo_pharma

LEO Pharma appoints two divisional directors

March 25, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LEO Pharma

LEO Pharma has made two new appointments to the leadership team of its UK/Ireland affiliate.Mike Williams (pictured) joins to head …

Actavis to invest in Florida facility

March 25, 2013 Manufacturing and Production Actavis, Watson

Actavis has announced a $40.5 million investment round at its plant in Davie, Florida, that looks set to create around …

Two Apotex facilities cited by FDA

March 25, 2013 Manufacturing and Production Apotex, FDA

Canadian generic drugmaker Apotex has been sent another warning letter by the FDA after violations were uncovered at two manufacturing …

Pharma manufacturing news in brief

March 22, 2013 Manufacturing and Production APIC, Agila, Avitide, Catalent, Contego, Malaysian Bio-XCell, Nueland Labs, ShangPharma, Zhejiang biotech

Agila to build a new facility in Malaysia, Avitide raises money for new bioprocessing technology, plus alliance and acquisition news …

Budget 2013: pharma ‘pleased’

March 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Budget, Osborne, UK

Pharma and health bodies have broadly given George Osborne’s Budget a warm welcome, with cuts in corporation tax, increased R&D …
steven_burrill-headshot-cropped

Targacept makes changes to Board and management

March 21, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept

Clinical-stage biopharma firm Targacept has announced several changes to its Board of directors and management. By the end of May …
screen_shot_2013-03-20_at_09

Ziarco appoints John LaMattina as R&D advisor

March 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LaMattina, Ziarco

Ex-global head of Pfizer R&D and Pharmafocus regular John LaMattina has been given a strategic advisory role by biotech firm …
The Gateway to Local Adoption Series

Latest content